| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |